This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Octapharma Ag. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Innovations by Ulrich Roessl: Pioneering High Concentration Immunoglobulin Composition
Introduction: Ulrich Roessl is a distinguished inventor based in Vienna, Austria, known for his contributions to the field of pharmaceutical compositions. With a total of two patents to his name, he has focused on developing innovative solutions that address critical medical needs.
Latest Patents: Roessl's most notable patents include the "High concentration immunoglobulin composition for pharmaceutical application." This invention pertains to a specialized liquid composition comprising polyclonal immunoglobulins, combined with viscosity-modulating amino acids such as arginine and histidine, along with stabilizing amino acids like glycine and proline. More than 90% of the polyclonal immunoglobulins exist in monomer or dimer forms, with less than 5% as polymers. The composition boasts an immunoglobulin concentration exceeding 160 g/L, with a pH range between 5.2 and 5.9. This innovative formulation is aimed at enhancing medical treatments utilizing concentrated polyclonal immunoglobulins and includes methods for effective formulation as well.
Career Highlights: Ulrich Roessl is affiliated with Octapharma AG, a company that specializes in the development of human protein products derived from human plasma and advanced recombinant technologies. His work at Octapharma AG reflects his commitment to advancing pharmaceutical science and improving patient outcomes through innovative compositions.
Collaborations: Throughout his career, Roessl has collaborated with esteemed colleagues, including Karin Ahrer and Waltraud Kaar. These partnerships have contributed to the successful development and refinement of his innovative pharmaceutical formulations.
Conclusion: Ulrich Roessl continues to make significant strides in the field of pharmaceuticals through his inventive spirit and dedication to medical advancement. His patented compositions are not only a testament to his ingenuity but also offer promising solutions for the future of medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile